Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue
- 1 September 1998
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (1) , 41-48
- https://doi.org/10.1038/sj.bjp.0702034
Abstract
1. The present study compared the cardiovascular effects of mibefradil (MIB), a novel Ca2+-channel antagonist with high selectivity for T-type Ca2+-channels to the effect of the L-type Ca2+-channel-antagonists nifedipine (NIF) and diltiazem (DIL) in left ventricular myocardium and coronary arteries of hearts obtained from patients suffering from dilated cardiomyopathy (NYHA IV). Right atrial myocardium from patients undergoing aortocoronary bypass surgery without signs of cardiac failure was studied as well. 2. NIF and DIL (100 micromol l(-1)) completely depressed force of contraction (FOC) in electrically driven left ventricular myocardium (NIF 6.5+/-1.4% and DIL 7.1+/-1.2% of control), whereas a similar concentration of MIB only reduced force of contraction to 55.1+/-4.0% of the basal FOC. The negative inotropic potency as measured by the concentration needed to reduce basal FOC for 25% was NIF (0.0095 micromol l(-1))>DIL (0.041 micromol l(-1))>MIB (9.47 micromol l(-1)). 3. All three Ca2+-channel antagonists were more potent in human atrial compared to human left ventricular myocardium to reduce FOC. 4. The rank order of Ca+-antagonistic moiety as measured by the decrease of the intracellular Ca2+-transient (fura-2 ratio method) was NIF>DIL>MIB. 5. All Ca2+-channel antagonists completely relaxed human coronary arteries (% of papaverine effect: MIB 81.7+/-5.5%, DIL 91.3+/-0.9%, NIF 96.4+/-3.7%) precontracted with PGF2alpha (0.3 micromol l(-1)). The rank order of vasodilatory potency was NIF (EC50; 0.02 micromol l(-1))>DIL (0.13 micromol l(-1))>MIB (2.05 micromol l(-1)). 6. The vasoselectivity measured by the ratio of the concentration needed to achieve a 25% decrease in force and the concentration needed for 25% vasodilatation was 316 for MIB, 1.5 for NIF and 1.0 for DIL. 7. The present study provides evidence that blockade of T-type Ca2+-channels (e.g. mibefradil) results in potent vasodilatory properties with only minor cardiodepressant effects.Keywords
This publication has 36 references indexed in Scilit:
- Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CDClinical Therapeutics, 1997
- Effect of inotropic interventions on contraction and Ca2+transients in the human heartJournal of Applied Physiology, 1997
- Contributions of Ca2+-influx via the L-type Ca2+-current and Ca2+-release from the sarcoplasmic reticulum to [Ca2+]i-transients in human myocytesBasic Research in Cardiology, 1997
- ?- and?-type Calcium Currents Differ in Finch and Rat Ventricular CardiomyocytesJournal of Molecular and Cellular Cardiology, 1995
- Chronic Treatment with the CA2+Channel Inhibitor RO 40-5967 Potentiates Endothelium-Dependent Relaxations in the Aorta of the Hypertensive Salt Sensitive Dahl RatBlood Pressure, 1994
- Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.Circulation, 1992
- Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failureJournal of Molecular and Cellular Cardiology, 1991
- Species Differences in the Negative Inotropic Response of 1,4-Dihydropyridine Calcium Channel Blockers in MyocardiumJournal of Cardiovascular Pharmacology, 1988
- Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs.Circulation Research, 1986
- Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology.The Journal of general physiology, 1985